Interim Management for Life Science
Proven leaders for pharma, biotech and medtech — within days.
When compliance and the pipeline can't wait
Nextt & Mason places proven interim executives in pharmaceutical, biotech and medtech companies across the Nordics — within days. Leaders who protect compliance, the pipeline and the path to market.
In life science, leadership is measured against regulators, milestones and patients. When a Head of Quality leaves weeks before an FDA inspection, a Phase III readout reshapes the strategy, or a launch slips because manufacturing cannot keep up, a leadership gap quickly becomes a risk — to approval, to supply and to the company's value.
In life science, a vacancy is never just a vacancy. It is a regulatory risk.
Contact us if you need an interim leader
Why life science companies require a different kind of leadership
Leading a life science company means balancing science, regulation and commerce — with timelines measured in years and every decision weighed against patient safety. Five forces define the Nordic life science landscape, and every interim leader we place has already led through them:
- Regulation and quality. GMP, GDP, EU MDR and IVDR, and FDA and EMA requirements leave no room for gaps. A vacant quality or regulatory role can stall a batch release, an inspection or an approval.
- From pipeline to market. Clinical data, regulatory submissions and market access must line up. Moving from clinical to commercial stage demands new capabilities — and a leadership team built for launch.
- Manufacturing and supply. Scaling production, tech transfer to CMOs and resilient supply chains decide whether demand can be met. Capacity is a strategic question, not just an operational one.
- Capital and partnerships. Biotech and medtech companies live by funding rounds, licensing deals and partnerships with big pharma. Investors and partners expect investor-grade reporting and sharp execution.
- Talent and growth. The Nordic life science cluster is growing fast, and executives with regulatory insight are scarce. Recruiting the right leader often takes longer than the business can wait.
When does a life science company need an interim manager?
A life science company typically brings in an interim manager when a key role falls vacant or a change cannot wait for a six-to-nine-month recruitment — time an inspection, a submission or a launch rarely allows. These are the situations we recognise:
- The Head of Quality, QA or Regulatory Affairs lead leaves ahead of an inspection or submission
- An inspection finding, a warning letter or a recall calls for immediate remediation
- The company moves from clinical to commercial stage and needs a leadership team built for launch
- A founder or CEO steps back, and the board needs an experienced leader for the next phase
- Production must scale, or manufacturing moves to a new site or partner
- A clinical setback, a missed milestone or a tighter cash position calls for a turnaround
- An acquisition or merger must be integrated quickly — including quality systems and regulatory responsibilities
- ERP, QMS or other validated systems must be implemented without compromising compliance
- A crisis — a supply disruption, a product issue or public attention — requires calm, experienced leadership
In every one of these situations, Nextt & Mason has been here before. We know what is at stake — and how to close the gap before it reaches the regulator, the market or the patient.
Contact us if you need an interim leader
Our Leaders
Our interim leaders for life science have run pharmaceutical, biotech and medtech companies, led quality and regulatory functions through inspections, taken products from clinical development to launch and built organisations that scale. They understand both the science and the business — and they lead from day one.
Every leader is carefully selected through extensive interviews, giving us deep insight into each profile and enabling a precise match to your challenge — whether you are a clinical-stage biotech, a medtech company preparing for launch or an established pharmaceutical manufacturer.
They step in within days, without long handovers. Independent and objective, they bring fresh eyes, clear priorities and decisive action — free of internal politics. They assume ownership, make decisions naturally and deliver with precision, pace and purpose — always with full confidentiality and a focus on achieving the promised results within the agreed timeframe.
FAQ – Interim management for life science
What is interim management in life science?
Interim management in life science means placing an experienced executive in a pharmaceutical, biotech or medtech company for a defined period — to close a leadership gap, lead a transition such as a launch or a remediation programme, or deliver a specific result. The leader understands regulatory requirements, quality systems and the path from pipeline to market, and is effective from day one. Nextt & Mason provides interim leaders to life science across the Nordics.
How quickly can Nextt & Mason place an interim leader in a life science company?
We typically place a qualified interim leader within days of the briefing. Because our leaders are assessed in depth through extensive interviews, we match them precisely to your company's stage, your regulatory situation and your organisation.
When should a life science company hire an interim Head of Quality?
When a quality or regulatory role falls vacant ahead of an inspection, a submission or a launch — or when an inspection finding requires fast remediation. An interim Head of Quality secures GMP compliance, leads the dialogue with the authorities and keeps batch release on track while you recruit permanently.
Do your leaders have experience with FDA and EMA?
Yes. Our network includes leaders who have prepared for and led FDA and EMA inspections, regulatory submissions and remediation programmes in pharmaceutical, biotech and medtech companies.
Which functions can interim leaders cover in a life science company?
